Cargando…

Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease with limited treatment options. N6-methyladenosine (m6A) is a reversible RNA modification and has been implicated in various biological processes. However, there are few studies on m6A in IPF. This project mainly explores the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiqiang, Shen, Lanyu, Wang, Junjie, Huang, Jiaqian, Tao, Huimin, Zhou, Xiumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744785/ https://www.ncbi.nlm.nih.gov/pubmed/36523766 http://dx.doi.org/10.3389/fgene.2022.1059325

Ejemplares similares

Weighted gene co-expression network analysis and CIBERSORT screening of key genes related to m6A methylation in Hirschsprung’s disease
por: Huang, Jiaqian, et al.
Publicado: (2023)

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
por: Zhang, Jingcheng, et al.
Publicado: (2023)

Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom
por: Shi, Guodong, et al.
Publicado: (2022)

Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

A prognostic model based on clusters of molecules related to epithelial–mesenchymal transition for idiopathic pulmonary fibrosis
por: Zhao, Jiarui, et al.
Publicado: (2023)

Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Management of BMI Is a Potential New Approach for the Prevention of Idiopathic Pulmonary Fibrosis
por: Ma, Yuchao, et al.
Publicado: (2022)

Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis
por: Fu, Chenkun, et al.
Publicado: (2023)

Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification
por: Huang, Tao, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Wang, Hongbo, et al.
Publicado: (2021)

A potential three-gene-based diagnostic signature for idiopathic pulmonary fibrosis
por: Wu, Yi, et al.
Publicado: (2023)

Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis
por: Zeng, Youjie, et al.
Publicado: (2023)

Integrative Analysis of Transcriptome-Wide Association Study and mRNA Expression Profiles Identifies Candidate Genes Associated With Idiopathic Pulmonary Fibrosis
por: Gong, Weiming, et al.
Publicado: (2020)

Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management
por: Yang, Changqing, et al.
Publicado: (2023)

Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension
por: Gao, Gufeng, et al.
Publicado: (2023)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis
por: Yao, Yuanshan, et al.
Publicado: (2022)

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2021)

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021)

Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis
por: Wang, Qing, et al.
Publicado: (2023)

Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma
por: Dai, Dongjun, et al.
Publicado: (2021)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer
por: Tian, Ye, et al.
Publicado: (2022)

Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma
por: Bai, Haiya, et al.
Publicado: (2021)

Identification of Potential Prognostic Biomarkers Associated With Macrophage M2 Infiltration in Gastric Cancer
por: Liu, Baohong, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

The mapping of mRNA alterations elucidates the etiology of radiation-induced pulmonary fibrosis
por: Yuan, Meng, et al.
Publicado: (2022)

CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
por: Li, Yupeng, et al.
Publicado: (2021)

Prognostic Implication of the m(6)A RNA Methylation Regulators in Rectal Cancer
por: Chen, Yajie, et al.
Publicado: (2021)

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
por: Aversa, Zaira, et al.
Publicado: (2023)

Identification of the Signature Associated With m(6)A RNA Methylation Regulators and m(6)A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung Adenocarcinoma
por: Guo, Bingzhou, et al.
Publicado: (2021)

Ferroptosis-Related Genes in Bronchoalveolar Lavage Fluid Serves as Prognostic Biomarkers for Idiopathic Pulmonary Fibrosis
por: Li, Meng, et al.
Publicado: (2021)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
por: Nakanishi, Yu, et al.
Publicado: (2021)

Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
por: Domvri, Kalliopi, et al.
Publicado: (2023)

Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
por: Yang, Shifeng, et al.
Publicado: (2022)

Identification and experimental validation of key m6A modification regulators as potential biomarkers of osteoporosis
por: Qiao, Yanchun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fntr8d8b6hkk79avdmpf9v1763